Overall rank by patents
#24,352
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 2 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Flospine holds 11 US patents across 2 technology areas, rank #24,352 of 50,000 tracked assignees.
Flospine, Llc has been granted 11 US utility patents between 2017 and 2025, placing Flospine, Llc at rank #24,352 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Flospine, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Flospine sits between Flextronics Automotive, Inc. (11 patents, rank #24,348) and Fluehs Drehtechnik Gmbh (11 patents, rank #24,356) - the closest US assignees by grant volume. The composite Innovation Score of 44.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 5 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Flospine, Llc's 17.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Flospine, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Flextronics Automotive, Inc.
11 patents
Flint Hills Resources, LP
11 patents
Flint Trading, Inc.
11 patents
Flo Technologies, Inc.
11 patents
Floreac N.V. div. MICROFLOR
11 patents
Florence Corporation
11 patents
Flow Neuroscience, Inc.
11 patents
Fluehs Drehtechnik GmbH
11 patents
FloSpine, LLC
11 patents
What this shows Flospine holds 11 patents at rank #24,352, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Flospine's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
44 Top 26% higher than 74% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 18.2% |
| 2018 | 3 | 27.3% |
| 2022 | 1 | 9.1% |
| 2023 | 1 | 9.1% |
| 2024 | 3 | 27.3% |
| 2025 | 1 | 9.1% |
Top 2 of 2 technology areas
Overall rank by patents
#24,352
Across all tracked assignees
44.3 out of 100
How to use this portfolio
Flospine's 11 grants land it in the top 26% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.